GlassScriptPhysician profile
Shelli H Hanks
NPI 1225201395
$1,679.68
in general payments reported to CMS, 2019-2025
23 companies · $373 in 2025
The $373 reported for 2025 was more than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $200 · 2020: $16.44 · 2021: $177 · 2022: $286 · 2023: $212 · 2024: $415 · 2025: $373.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,000.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $376.01 | 2023-2025 | Orgovyx |
| Myovant Sciences INC. | $287.49 | 2021-2022 | |
| Blue Earth Diagnostics | $164.78 | 2019-2025 | Posluma |
| Teleflex LLC | $123.54 | 2024-2025 | Urolift, Barrigel |
| Bayer Healthcare Pharmaceuticals INC. | $108.50 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $88.19 | 2023-2024 | Cosentyx |
| Siemens Medical Solutions USA, INC. | $63.60 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $59.95 | 2023-2025 | Lynparza |
| Ferring Pharmaceuticals INC. | $46.49 | 2024 | Adstiladrin |
| Boston Scientific Corporation | $40.53 | 2019-2025 | Spaceoar Vue System - 10ml |
| Palette Life Sciences, INC. | $38.80 | 2023 | |
| Abbvie INC. | $35.68 | 2019-2020 | |
| Urogen Pharma, INC. | $34.19 | 2025 | |
| Dendreon Pharmaceuticals LLC | $32.06 | 2019-2021 | |
| Amgen INC. | $27.16 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Progenics Pharmaceuticals, INC. | $24.85 | 2024 | |
| Cardinal Health 414 LLC | $23.87 | 2024 | |
| Calyxo, INC. | $22.03 | 2023 | Cvac Aspiration System |
| Coopersurgical, INC. | $20.80 | 2024 | Advincula Delineator Uterine Manipulator |
| Janssen Biotech, INC. | $17.41 | 2022 | |
| Tolmar Pharmaceuticals, INC. | $17.29 | 2021 | |
| Pfizer INC. | $15.66 | 2024 | |
| Endo Pharmaceuticals INC. | $10.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shelli Hanks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.